Stock data
Oruka Therapeutics, Inc. (ORKA)
Oruka Therapeutics, Inc. (ORKA) reported net income of -US$105.43M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$122.05M | -US$105.43M | — |
| 2024 | — | — | -US$88.12M | -US$83.72M | — |
| 2023 | US$0.00M | — | -US$7.30M | -US$5.34M | — |
| 2022 | US$0.00M | — | -US$10.60M | -US$9.93M | — |
| 2021 | US$0.00M | — | -US$19.34M | -US$19.32M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$41.21M | — |
| 2026-03-31 | — | -US$31.82M | — |
| 2025-12-31 | — | -US$29.58M | — |
| 2025-09-30 | — | -US$30.28M | — |
| 2025-06-30 | — | -US$24.57M | — |
| 2025-03-31 | — | -US$21.00M | — |
| 2024-12-31 | — | -US$30.85M | — |
| 2024-09-30 | — | -US$28.62M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.